A Home-Based Study to Enhance Activity in Breast Cancer Survivors
1 other identifier
interventional
13
1 country
1
Brief Summary
There is a well-documented association between physical activity \& risk for breast cancer development and recurrence. It is known that exercise interventions have been effective at increasing physical activity levels in breast cancer survivors. Knowing that breast cancer survivors are less active than non-cancer patients, a less active lifestyle places them at risk of obesity and poor overall health, which in turn also increases risk of cancer and cancer recurrence. Not all the reasons for the risk reduction are clear, however it is known that hormones and other inflammatory markers play a role. This study has three goals:
- 1.To investigate the feasibility of a home intervention designed to reduce sedentary behavior.
- 2.Describe the effects of the intervention on levels of sedentary behavior, physical activity, and symptoms.
- 3.Assess cost of the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable breast-cancer
Started Oct 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 2, 2016
CompletedFirst Posted
Study publicly available on registry
November 21, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2018
CompletedJuly 17, 2019
July 1, 2019
2 years
November 2, 2016
July 16, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Sedentary Time
Change in minutes/day of sedentary time as recorded by ActivPal in all 25 participants pre and post intervention.
8 weeks
Secondary Outcomes (15)
Activity Level
8 weeks
Glucose
8 weeks
Insulin
8 weeks
Total cholesterol
8 weeks
High density lipoprotien cholesterol
8 weeks
- +10 more secondary outcomes
Study Arms (1)
Reduced Sedentary Time Intervention
OTHERReduced Sedentary Time Intervention (RSTI)
Interventions
Following 7 days of baseline activity monitoring a study investigator will download the information from the monitor, evaluate the periods of sedentary behavior and create a tailored RSTI for each participant. For example, the investigator may notice a long stretch of sitting in the evening following a meal and identify several exercises that can be done indoors during that time, or if the participant is amiable to walking breaks and a period after work is identified the investigator might suggest the appropriate walking activity at that time. This program has been successful in sedentary overweight office workers and investigators will use similar techniques.
Eligibility Criteria
You may qualify if:
- Stage I-III breast cancer survivors 20-80 who have completed primary treatment (surgery, radiation and/or chemotherapy) greater than 6 months but less than 5 years ago. Patients may be on adjuvant hormonal therapy
- BMI \> 25 (overweight or class I/II obese)
- Not meeting current guidelines for regular exercise as defined by less than 150 minutes a week of moderate to vigorous physical activity
- No gain or loss of \>10% body weight over the prior 6 months.
You may not qualify if:
- Known diabetes
- Known coronary artery disease
- Pregnancy
- Any injury that would limit mobility or require use of assisted mobility devices
- Weight gain or loss of \>10% body weight over the prior 6 months
- Greater than 150 minutes a week of moderate to vigorous physical activity
- Inability to provide informed consent
- Non-english speaking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Baystate Medical Centerlead
- University of Massachusetts, Amherstcollaborator
Study Sites (1)
Baystate Medical Center
Springfield, Massachusetts, 01109, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Grace Makari-Judson, MD
Baystate Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 2, 2016
First Posted
November 21, 2016
Study Start
October 1, 2016
Primary Completion
October 1, 2018
Study Completion
October 1, 2018
Last Updated
July 17, 2019
Record last verified: 2019-07